Dimethylaminododecyl Methacrylate-Incorporated Dental Materials Could Be the First Line of Defense against .

Oral cavity is an essential reservoir for . We aimed to investigate the antibacterial effects of dimethylaminododecyl methacrylate (DMADDM) against . Modified giomers were prepared by introducing 0%, 1.25% and 2.5% DMADDM monomers. Broth microdilution assay, spot assay, Alamer Blue assay, PMA-qPCR, crystal violet staining, scanning electron microscopy observation and live/dead bacterial staining were performed to evaluate the antibacterial and antibiofilm effects of DMADDM and modified giomers in vitro. Urease assay, qPCR, hematoxylin-eosin staining and ELISA were performed to evaluate the inflammation levels and colonization of in vivo. In vitro experiments indicated that the minimum inhibitory concentration and minimum bactericidal concentration of DMADDM were 6.25 μg/mL and 25 μg/mL, respectively. It inhibited in a dose- and time-dependent manner, and significantly reduced the expression of , , and . DMADDM-modified giomers inhibited the formation of biofilm and reduced live cells within it. In vivo experiments confirmed that the pretreatment with DMADDM-modified dental resin effectively reduced the gastric colonization of oral-derived , suppressed systemic and local gastric inflammation. DMADDM monomers and DMADDM-modified giomers possessed excellent antibacterial and antibiofilm effects on . Pretreatment with DMADDM-modified giomers significantly inhibited the gastric infection by .